LPL Financial’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-69
Closed -$25.2K 4699
2023
Q2
$25.2K Buy
69
+4
+6% +$1.81K ﹤0.01% 4496
2023
Q1
$43.3K Hold
65
﹤0.01% 4323
2022
Q4
$56.7K Sell
65
-6
-8% -$7.55K ﹤0.01% 4243
2022
Q3
$77K Buy
71
+12
+20% +$15.9K ﹤0.01% 4160
2022
Q2
$48K Buy
59
+4
+7% +$4.12K ﹤0.01% 4240
2022
Q1
$86K Buy
55
+4
+8% +$5.4K ﹤0.01% 4002
2021
Q4
$92K Buy
51
+11
+28% +$29.4K ﹤0.01% 4151
2021
Q3
$132K Hold
40
﹤0.01% 4083
2021
Q2
$174K Sell
40
-4
-9% -$15.8K ﹤0.01% 3944
2021
Q1
$213K Buy
44
+26
+144% +$147K ﹤0.01% 3727
2020
Q4
$33K Buy
+18
New +$6.73K ﹤0.01% 3756

Other funds holding BNGO

LPL Financial's BNGO Position: Q3 2023 in Review

LPL Financial sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 69 shares — an estimated $25.2K sold.

LPL Financial first reported a position in BNGO in Q4 2020 and held it in 11 quarters. The position peaked at $213K in Q1 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • LPL Financial reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • LPL Financial sold 69 Bionano Genomics shares in Q3 2023, an estimated $25.2K.
  • LPL Financial first reported a position in Bionano Genomics in Q4 2020 and held it in 11 quarters.
  • LPL Financial's Bionano Genomics position peaked at $213K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on LPL Financial's 13F filing for Q3 2023, filed 13 Nov 2023.